The size of the Sleep Apnea Devices market in the Asia Pacific is valued at USD 1.6 billion in 2019 and is expected to grow at a CAGR of 7.9% to reach USD 2.35 billion by 2024 during the forecast period. It captures 20% of the global market.
When the airway is blocked during sleep it causes sleep Apnea. It has many negative effects if left untreated. Some of those effects are hypertension, cardiovascular diseases, impotency, etc. The main cause of the problem is the oxygen deficiency. It also distorts the sleep cycle as the person is jerked awake because of the reflex action of the brain to heightened carbon dioxide levels. Sleepiness and tiredness are a few symptoms of this disease. Several medical devices are used for the treatment of this disease.
Growing awareness regarding hypertension and other prevalent chronic diseases, rapid advancements in technology resulting in the development of enhanced and improved techniques of treatment, high stress, long working hours, and increasing cases of depression and obesity are the key factors contributing towards high market growth.
However, expensive treatment procedures and high discomfort are inhibiting the growth of this market.
It is the largest market segment and also predicted to be the fastest-growing market category in the forecast period. PAP accounted for the largest market share in 2018. However, oral market sub-segment is predicted to be the fastest-growing market segment in the forecast period. PSG market category captured the largest market share. However, the single-channel device is expected to grow fastest in the forecast period. It is painless and non-invasive which is the reason for the observable trend mentioned above.
It is the second-fastest-growing market with China and India spearheading its growth spurt.
This research report on the Asia Pacific Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories.
Promising companies leading the Asia Pacific Sleep Apnea Devices Market are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Sleep Apnea Therapeutic Devices Market
5.1.2.1 Positive Airway Pressure (PAP) Devices
5.1.2.1.1 CPAP Devices
5.1.2.1.2 APAP Devices
5.1.2.1.3 BPAP Devices
5.1.2.2 Facial Interfaces
5.1.2.2.1 Masks
5.1.2.2.1.1 Nasal Masks
5.1.2.2.1.2 Nasal Pillow Masks
5.1.2.2.1.3 Full-Face Masks
5.1.2.3 Adaptive Servo-Ventilation Instruments (ASV)
5.1.2.4 Airway Clearance Systems
5.1.2.5 Oxygen Concentrators
5.1.2.5.1 Stationary Concentrators
5.1.2.5.2 Portable Concentrators
5.1.2.6 Accessories
5.1.2.6.1 Pillows
5.1.2.6.2 Chin Restraints
5.1.2.6.3 Mask Cleaning Wipes
5.1.2.6.4 Other Accessories
5.1.2.7 Oral Appliances
5.1.2.7.1 Mandibular Advancement Devices
5.1.2.7.2 Tongue Retaining Devices
5.1.3 Sleep Apnea Diagnostic Devices Market
5.1.3.1 Polysomnography Devices
5.1.3.1.1 Ambulatory PSG Devices
5.1.3.1.2 Clinical PSG Devices
5.1.3.2 Respiratory Polygraphs
5.1.3.3 Single-Channel Screening Devices (Pulse Oximeters)
5.1.3.3.1 Fingertip Pulse Oximeters
5.1.3.3.2 Handheld Pulse Oximeters
5.1.3.3.3 Wrist-Worn Pulse Oximeters
5.1.3.3.4 Tabletop Pulse Oximeters
5.1.3.4 Actigraphy Systems
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Home Care Setting
5.2.3 Sleep Laboratories and Hospitals
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Resmed, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Philips Healthcare
8.3 Fisher & Paykel Healthcare Ltd.
8.4 Somnomed Limited
8.5 Compumedics Limited
8.6 Weinmann Medical Devices GmbH
8.7 Whole You, Inc.
8.8 Devilbiss Healthcare LLC
8.9 BMC Medical Co., Ltd.
8.10 Braebon Medical Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
